Certain cancer cells are proposed to have high levels of activated BAK sequestered by MCL1 or BCLX<sub>L</sub>, thus priming these cells to undergo apoptosis in response to BH3 mimetic compounds that target MCL1 or BCLX<sub>L</sub>. This evidence concerns the gene BCL2L1 and cancer.